[Capital Cube] PRA Health Sciences Inc (NASDAQ:PRAH)(TREND ANALYSIS) Share Price Performance Relative to Peers
PRAH-US has traded publicly for less than a year.
PRAH-US‘s shares have traded publicly for less than a year. Over the last one month, however, the company’s share price has relatively outperformed with a return of -3.00% vs. peer median of -7.55%.
Stock Performance: Click here for a free comprehensive Trend Analysis Report
PRA Health Sciences Inc (NASDAQ:PRAH) stock is currently trading 1.96% below its 52-week-high, 137.91% above its 52-week-low. The 1-year stock price history is in the range of $19.1 – $46.35. PRA Health Sciences Inc (PRAH) has a price to earnings ratio of 307.03 versus Healthcare sector average of 53.82. PRAH stock price has outperformed the Nasdaq by 83.6%. The Medical Drugs company is currently valued at $2.73 billion and its share price closed the last trading session at $45.44. The stock has a 50-day moving average of $40.47 and a 200-day moving average of $34.58.
PRA Health Sciences Inc (PRAH) current short interest stands at 2.34 million shares. It has increased by 25% from the same period of last month. Around 12% of the company’s shares, which are float, are short sold. With a 10-days average volume of 0.16 million shares, the number of days required to cover the short positions stand at 14.5 days.
The company is expected to announce next quarter earnings on October 26, at consensus estimate of $0.41.
Is this a Buying Opportunity? Click here for a free Trend Analysis Report
There are currently eight analysts that cover PRA Health Sciences Inc stock. Of those eight, six have a Buy rating, two have a Hold rating. On a consensus basis this yields to an Overweight rating. The consensus target price stands at $46.4.
A recent analyst activity consisted of Credit Suisse who resumed their coverage on the stock with Outperform rating on August 14. Credit Suisse decreased price target from $47 to $47. This corresponds to a 3.43% upside from the last closing price. On the date of report, the stock closed at $41.12.
KeyBanc initiated their coverage on the stock with Sector Weight rating on July 2. On the date of report, the stock closed at $35.95.
Another research firm was Jefferies who reiterated their Buy stance on May 27. Jefferies increased their price target on PRA Health Sciences Inc from $36 to $38. This translates to a 16.37% downside from the last closing price. On the date of report, the stock closed at $32.73.
Company profile
PRA Health Sciences, Inc. is a global contract research organization. The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries.
The post PRA Health Sciences Inc (NASDAQ:PRAH) Stock Might be a Great Pick appeared first on Street Report.